Filing Details

Accession Number:
0000914190-16-000824
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-08 16:02:40
Reporting Period:
2016-08-15
Filing Date:
2016-09-08
Accepted Time:
2016-09-08 16:02:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1195116 Arno Therapeutics Inc ARNI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1044734 Donald S Sussman C/o Hewlett Bay Associates Llc
800 Westchester Avenue, Suite S-414
Rye Brook NY 10573
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-15 714,285 $0.00 714,285 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2016 Series F Warrants (right to buy) Acquisiton 2016-08-15 357,142 $0.00 357,142 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
357,142 2016-08-15 2021-08-15 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,472,905 Indirect By Commercial Street Capital, LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock 2012 Series A Warrants $1.17 2013-10-29 2017-11-26 1,780,625 1,780,625 Indirect
Common Stock 2013 Series D Warrants $1.81 2013-10-29 2018-10-29 1,523,207 1,523,207 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-11-26 1,780,625 1,780,625 Indirect
2018-10-29 1,523,207 1,523,207 Indirect
Footnotes
  1. CSC has a contractual right to designate one member of the Issuer's board of directors and has designated Steven B. Ruchefsky, a director of the Issuer, pursuant to such right. Accordingly, the Reporting Person, as a co-managing director of CSC, may be deemed to be a director by deputization for purposes of Section 16 of the Exchange Act.
  2. The reported securities are included within 714,285 Issuer units purchased by the Reporting Person for $0.35 per unit. Each unit consists of one share of common stock and a 2016 Series F Warrant to purchase one-half share of common stock.
  3. Represents securities of the Issuer directly held by Commercial Street Capital LLC ("CSC"). The Reporting Person is a co-managing member of CSC and as such may be deemed to beneficially own the securities held by CSC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  4. As a result of the Issuer's 8/15/16 private placement of common stock and Series F Warrants, the exercise prices and shares underlying the 2012 Series A Warrants and 2013 Series D Warrants were automatically adjusted to the exercise price and shares reflected pursuant to anti-dilution adjustment provisions in such warrants.